Download

We have an awesome time speaking with SSDP’s Drug Education Manager, Dr. Vilmarie Narloch. Vilmarie is making a big difference with drug safety in the US and internationally with SSDP’s education program ‘Just Say Know.’

During the show we discuss Vilmarie’s work with policy around the Good Samaritan laws and other impressive and impactful harm reduction projects. We also discuss some of the pressure from various elements in the government regressing rules, like some law enforcement offices refusing to use Narcannaloxone to help save the lives of people overdosing.

This episode is a dose of compassion and gives perspective about the different impacts from the drug war and prohibition.

If you are a student who wishes to get involved in drug policy work, please check out the work that SSDP is doing. If you do not have a chapter at your school or university, start one today!

Vilmarie also joins us in our course Navigating Psychedelics for a master class featuring harm reduction strategies and more. Be sure to sign up today to learn more from Vilmarie and many others!

About Students For Sensible Drug Policy (SSDP)

Students for Sensible Drug Policy (SSDP) is the only international network of students dedicated to ending the war on drugs. At its heart, SSDP is a grassroots organization, led by a student-run Board of Directors. We create change by bringing young people together and creating safe spaces for students of all political and ideological stripes to have honest conversations about drugs and drug policy. Founded in 1998, SSDP is comprised of thousands of members at hundreds of campuses in countries around the globe.

About Just Say Know

Just Say Know is a series of drug education modules aimed at promoting open and honest dialogue around commonly used substances. The program aims to equip young people with harm reduction tools and skills as it relates to the specific substance, but can be applied to substance use generally.

Students for Sensible Drug Policy believes that students should be an overall part of any campus and community prevention and intervention strategy. Our SSDP Peer Education program seeks to empower students in our network to analyze the relationship between drug policy and drug use by providing evidence-based drug information, teaching students to recognize and address dangerous behaviors and unhealthy attitudes, and promoting prosocial and harm reduction oriented behaviors and attitudes.

---

Show Notes/Links

• Students for Sensible Drug Policy
• Vilmarie Narloch – SSDP Staff Profile
• Fentanyl Test Strips
• Naloxone – The Fight for the Overdose Cure – The Atlantic
• SSDP’s 911 Good Samaritan Policy Guide
• Drug Overdose Immunity and Good Samaritan Laws
• Ohio’s police chief and refusal of Narcan 

Vilmarie Narloch PsyD. – Bio

Vilmarie Narloch, PsyD., is the Drug Education Manager at Students for Sensible Drug Policy. In this role, Vilmarie oversees the development and implementation of the SSDP Peer Education program, which is a training program for SSDP Members to become certified to deliver our drug education program, Just Say Know, to their peers. Vilmarie is passionate about reforming drug education in the U.S. and abroad, and has dedicated years of study on the topic for her dissertation. Vilmarie has taken on this position because as an organization driven by students with exceptional knowledge on drug policy and other drug use related issues, SSDP is uniquely positioned and qualified to be developing a drug education program. Additionally, Vilmarie educates staff and the network on the current state of research and treatment issues with regard to substance use disorders and mental health. Vilmarie aims to aid in the connection of policy and practice by helping our network understand the impact of policy on access to treatment and care while utilizing the latest research.

Vilmarie earned her M.A. in Counseling and Psychological Services from Saint. Mary’s University of Minnesota, and a Psy.D. in Clinical Psychology. During her time at Roosevelt, she was a graduate research assistant with Roosevelt University’s Illinois Consortium on Drug Policy. Her work at ICDP included research support, report co-authorship and event planning and coordination. Vilmarie’s interests in drug education, access to treatment, and harm reduction policy and practice have led her to numerous projects, including the provision of counseling and harm reduction services to students at the School of the Art Institute of Chicago and DePaul University, serving as a member of the Chicago Consortium on College Alcohol Harm Reduction, a predoctoral internship in the Adult Behavioral Services department in a local public health department, and a postdoctoral fellowship in a small prviate agency, where she provided therapy for individuals, couples, families, and groups in addition to supervising interns. Additionally, Vilmarie has been an adjunct instructor teaching undergraduate and graduate courses in psychology and substance use disorder treatment. She has dedicated her studies and clinical work to advance Harm Reduction as the standard of practice for substance use disorders. In doing so, she has sought opportunities to educate others in her field about harm reduction, including her students. Vilmarie’s dissertation, titled, “What Youth Want: Developing a Drug Education Curriculum Based on Youth Guidance and Evidence-Based Principles,” inspired her to continue to advocate for effective drug education on a professional level, which led to her current position at SSDP. Additionally, Vilmarie’s next personal career goal is to become trained to deliver psychedelic psychotherapy, which she considers to be the future of psychological practice.

Download

The MAPS Psychedelic Science 2017 conference was the largest psychedelic conference in history to date. It is an exciting time to be part of the movement and to get involved in the field. There is a push to legalize psychedelics for therapy and to recognize these substances as medicine. While the field needs the science and research to legitimize psychedelics as medicines to treat various disorders, but the change in status does not mean access for everyone. This is not to discourage the research or science, we acknowledge that it is important, but rather it is to help educate the public that the change in status does not mean psychedelics will be legal for recreational use.

There may be a misconception floating around that once MDMA or psilocybin becomes medicine there will be greater access. This is not entirely true according to Jag Davies. The criminalization of psychedelic substances will continue despite the health and clinical applications. Jag and the DPA strive to help move drug policy away from a criminalization approach and help to move it towards a more health-based approach.

In this episode, we talk with Jag Davies, Communication Strategy Director of the Drug Policy Alliance (DPA). Jag provides us with his insights about the current state of psychedelics, psychedelic research, and other drug laws. Jag also talks about his work with the DPA and what the DPA’s mission is. We discuss drug policy, advocacy, harm reduction, scheduling vs penalty, racism, and so much more.

One of the best things to do to get involved is to help spread the word about the healing potential of psychedelic medicines and substances. The policy around these substances are constantly changing and new issues are always arising. We talk a lot about privilege in this episode, and how being in a privileged position makes it easier to speak about experiences with psychedelics or other substances.

The Drug Policy Alliance (DPA) is the nation’s leading organization promoting drug policies that are grounded in science, compassion, health and human rights.

Our supporters are individuals who believe the war on drugs is doing more harm than good. Together we advance policies that reduce the harms of both drug use and drug prohibition, and seek solutions that promote safety while upholding the sovereignty of individuals over their own minds and bodies. We work to ensure that our nation’s drug policies no longer arrest, incarcerate, disenfranchise and otherwise harm millions – particularly young people and people of color who are disproportionately affected by the war on drugs.

Mission and Vision of the Drug Policy Alliance

The Drug Policy Alliance envisions a just society in which the use and regulation of drugs are grounded in science, compassion, health and human rights, in which people are no longer punished for what they put into their own bodies but only for crimes committed against others, and in which the fears, prejudices and punitive prohibitions of today are no more.

Our mission is to advance those policies and attitudes that best reduce the harms of both drug use and drug prohibition, and to promote the sovereignty of individuals over their minds and bodies.

Show Notes/Links

• Psychedelic Justice: How Do We Repair the Harms of Psychedelic Prohibition? By Jag Davies (MAPS Bulletin Spring 2017: Vol. 27, No. 1 – Special Edition: Psychedelic Science)
  • PDF Download
• Drug Policy Alliance Website
• Reform Conference (October 11th-14th in Atlanta, Georgia)
  • Scholarship for Reform Conference (Ends June 9th)
• The DPA’s Office of Academic Engagement 
• Stefanie Jones (DPA) – Safer Partying
  • Twitter
• Scheduling vs penalty
• 1.5 million drug arrests annually – most for simple possession
  • Enforcement only makes it more dangerous.
• New York City’s Stop & Frisk Policy
• Guide to Drug Combination Chart
• 
• End of Life Liberty Project
• Andrew Tatarsky and the Center for Optimal Living
• The International Center for Ethnobotanical Education, Research & Service (ICEERS)
• Nicholas Powers

About Jag Davies

From Drug Policy Alliance:

As director of communications strategy, Jag Davies works with communications, program, development and senior management staff to oversee production of all DPA publications and to facilitate best practices in the implementation of the organization’s messaging and brand identity.  Davies manages a team that includes DPA’s research coordinator and communications coordinator, as well as external consultant relationships with writers, designers, and multimedia content producers.

Davies also plays a key role in DPA’s media work.  He is regularly quoted in a wide range of media outlets and his writings have appeared in the New York Times, Washington Post, BBC.com, CNN.com, and dozens of regional and online publications.

Davies has more than a decade of professional experience working to establish drug policies grounded in science, compassion, health and human rights.  Before joining the organization, he served as director of communications for MAPS, a nonprofit pharmaceutical company conducting clinical trials aimed at developing marijuana and certain psychedelic drugs into federally-approved prescription medicines.  Davies also previously served as policy researcher for the American Civil Liberties Union (ACLU) Drug Law Reform Project (now known as the Criminal Law Reform Project), where he coordinated local, state, federal, and international efforts to end punitive drug policies that cause the widespread violation of constitutional and human rights.